Literature DB >> 24769079

HLA epitope based matching for transplantation.

René J Duquesnoy1.   

Abstract

As important risk factors for transplant rejection and failure, HLA antibodies are now recognized as being specific for epitopes which can be defined structurally with amino acid differences between HLA alleles. Donor-recipient compatibility should therefore be assessed at the epitope rather than the antigen level. HLAMatchmaker is a computer algorithm that considers each HLA antigen as a series of small configurations of polymorphic residues referred to as eplets as essential components of HLA epitopes. It includes epitopes on antigens encoded by all HLA-A, B, C, DR, DQ and DP loci as well as MICA. HLA epitopes have two characteristics namely antigenicity, i.e. the reactivity with antibody and immunogenicity, i.e. the ability of eliciting an antibody response. This article addresses the relevance of determining epitope-specificities of HLA antibodies, the effect of epitope structure on technique-dependent antibody reactivity and the identification of acceptable mismatches for sensitized patients considered for transplantation. Permissible mismatching for non-sensitized patients aimed to prevent or reduce HLA antibody responses could consider epitope loads of mismatched antigens and the recently developed nonself-self paradigm of epitope immunogenicity.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acceptable mismatch; Eplet; HLA antibody; HLA epitope; HLAMatchmaker; Permissible mismatch

Mesh:

Substances:

Year:  2014        PMID: 24769079     DOI: 10.1016/j.trim.2014.04.004

Source DB:  PubMed          Journal:  Transpl Immunol        ISSN: 0966-3274            Impact factor:   1.708


  20 in total

Review 1.  Effect of Immunosuppressive Drugs on Humoral Allosensitization after Kidney Transplant.

Authors:  Olivier Thaunat; Alice Koenig; Claire Leibler; Philippe Grimbert
Journal:  J Am Soc Nephrol       Date:  2016-02-12       Impact factor: 10.121

2.  Eplet Mismatch Load and De Novo Occurrence of Donor-Specific Anti-HLA Antibodies, Rejection, and Graft Failure after Kidney Transplantation: An Observational Cohort Study.

Authors:  Aleksandar Senev; Maarten Coemans; Evelyne Lerut; Vicky Van Sandt; Johan Kerkhofs; Liesbeth Daniëls; Marleen Vanden Driessche; Veerle Compernolle; Ben Sprangers; Elisabet Van Loon; Jasper Callemeyn; Frans Claas; Anat R Tambur; Geert Verbeke; Dirk Kuypers; Marie-Paule Emonds; Maarten Naesens
Journal:  J Am Soc Nephrol       Date:  2020-08-06       Impact factor: 10.121

Review 3.  Human leukocyte antigens and alloimmunization in heart transplantation: an open debate.

Authors:  Antonietta Picascia; Vincenzo Grimaldi; Amelia Casamassimi; Maria Rosaria De Pascale; Concetta Schiano; Claudio Napoli
Journal:  J Cardiovasc Transl Res       Date:  2014-09-05       Impact factor: 4.132

4.  High-resolution human leukocyte antigen typing and early post-transplant outcomes: more than meets the eye.

Authors:  Annelore Sacreas; Stijn E Verleden
Journal:  Ann Transl Med       Date:  2020-02

5.  High-throughput sequencing defines donor and recipient HLA B-cell epitope frequencies for prospective matching in transplantation.

Authors:  Jenny N Tran; Oliver P Günther; Karen R Sherwood; Franz Fenninger; Lenka L Allan; James Lan; Ruth Sapir-Pichhadze; Rene Duquesnoy; Frans Claas; Steven G E Marsh; W Robert McMaster; Paul A Keown
Journal:  Commun Biol       Date:  2021-05-14

6.  Anti-CMV-IgG positivity of donors is beneficial for alloHSCT recipients with respect to the better short-term immunological recovery and high level of CD4+CD25high lymphocytes.

Authors:  Emilia Jaskula; Dorota Dlubek; Agnieszka Tarnowska; Janusz Lange; Monika Mordak-Domagala; Krzysztof Suchnicki; Mariola Sedzimirska; Agata Borowik; Sylwia Mizia; Andrzej Lange
Journal:  Viruses       Date:  2015-03-23       Impact factor: 5.048

Review 7.  B Cell Immunity in Solid Organ Transplantation.

Authors:  Gonca E Karahan; Frans H J Claas; Sebastiaan Heidt
Journal:  Front Immunol       Date:  2017-01-10       Impact factor: 7.561

Review 8.  HLA Epitopes: The Targets of Monoclonal and Alloantibodies Defined.

Authors:  Nadim El-Awar; Vadim Jucaud; Anh Nguyen
Journal:  J Immunol Res       Date:  2017-05-24       Impact factor: 4.818

Review 9.  Clinically relevant interpretation of solid phase assays for HLA antibody.

Authors:  Maria P Bettinotti; Andrea A Zachary; Mary S Leffell
Journal:  Curr Opin Organ Transplant       Date:  2016-08       Impact factor: 2.640

Review 10.  Reflections on HLA Epitope-Based Matching for Transplantation.

Authors:  Rene J Duquesnoy
Journal:  Front Immunol       Date:  2016-11-28       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.